Medtronic plc (MDT)
| Market Cap | 129.94B |
| Revenue (ttm) | 34.76B |
| Net Income (ttm) | 4.76B |
| Shares Out | 1.28B |
| EPS (ttm) | 3.69 |
| PE Ratio | 27.47 |
| Forward PE | 17.31 |
| Dividend | $2.84 (2.80%) |
| Ex-Dividend Date | Sep 26, 2025 |
| Volume | 5,157,904 |
| Open | 102.11 |
| Previous Close | 101.99 |
| Day's Range | 101.31 - 102.46 |
| 52-Week Range | 79.29 - 106.33 |
| Beta | 0.72 |
| Analysts | Buy |
| Price Target | 108.63 (+7.17%) |
| Earnings Date | Nov 18, 2025 |
About MDT
Medtronic plc develops, manufactures, and sells device-based medical therapies to healthcare systems, physicians, clinicians, and patients in the United States, Ireland, and internationally. The Cardiovascular Portfolio segment offers implantable cardiac pacemakers, cardioverter defibrillators, and cardiac resynchronization therapy devices; cardiac ablation products; insertable cardiac monitor systems; TYRX products; and remote monitoring and patient-centered software. It also provides aortic valves, surgical valve replacement and repair produc... [Read more]
Financial Performance
In 2025, Medtronic's revenue was $33.54 billion, an increase of 3.62% compared to the previous year's $32.36 billion. Earnings were $4.66 billion, an increase of 26.82%.
Financial StatementsAnalyst Forecast
According to 18 analysts, the average rating for MDT stock is "Buy." The 12-month stock price target is $108.63, which is an increase of 7.17% from the latest price.
News
Medtronic announces cash dividend for third quarter of fiscal year 2026
GALWAY, Ireland , Dec. 4, 2025 /PRNewswire/ -- The board of directors of Medtronic plc (NYSE: MDT) on Thursday, December 4, 2025, approved the company's cash dividend for the third quarter of fiscal y...
Prediction: 1 Healthcare Giant Set to Soar in 2026
Medtronic recently delivered strong quarterly results thanks to a fast-growing franchise. This tailwind, along with others, could help maintain the stock's momentum into 2026.
Medtronic announces FDA clearance of Hugo™ robotic-assisted surgery system for urologic surgical procedures
Hugo RAS system brings choice to the U.S., coupled with the full suite of Medtronic surgical offerings, ultimately creating a connected and integrated operating room today and into the future. GALWAY,...
Medtronic begins U.S. commercial launch of the MiniMed™ 780G system with the Instinct sensor, made by Abbott
GALWAY, Ireland , Dec. 2, 2025 /PRNewswire/ -- Medtronic (NYSE: MDT), a global leader in healthcare technology, today announced the broad U.S. commercial launch of the MiniMed™ 780G system integrated...
3 Stocks to Buy and Hold: the Long-Term Play for Your Portfolio
Intuitive Surgical shows why now is a good time to consider buying surgical-robot competitor Medtronic. Eli Lilly helps explain why down-and-out drugmaker Pfizer could be worth a close look for long-t...
Best Dividend Aristocrats For December 2025
The ProShares S&P 500 Dividend Aristocrats ETF (NOBL) has underperformed the SPDR S&P 500 ETF (SPY) year-to-date, but November shows a reversal. Several Dividend Aristocrats, including CAH, CAT, CHRW,...
Robotics can 'democratize good healthcare' worldwide: Medtronic CEO
Medtronic Chairman and CEO Geoffrey Martha discusses the company's latest robotic innovation and how robotics can impact healthcare on 'The Claman Countdown.' #fox #media #us #usa #new #news #foxbusin...
5 Top Dividend Stocks to Buy in November
For investors, it's generally wise to buy and hold companies that continually raise their dividends. There are deals in energy, healthcare, consumer staples, and even the tech space.
This Medtech Giant's Stock Is Soaring. Should You Buy It Ahead of 2026?
Medtronic not only performed better than expected in its most recent quarter, but also raised its guidance. The company's innovation is paying off, and will do so again as it launches new products.
Which 'Dividend Prince' Will Become The Next King In 2 Years?
Medtronic has increased its dividend payment for 48 consecutive years. The global healthcare technology company has a very healthy dividend.
What Are the Best Healthcare Stocks to Buy Now? I Think It's Intuitive Surgical (ISRG) -- or, to Play It Safer, Medtronic (MDT)
Intuitive Surgical is the 800-pound gorilla in the robotic surgery space. Medtronic is entering the field and pays a solid dividend, too.
2 Fantastic Dividend Stocks to Buy and Hold Forever
Abbott and Medtronic are innovative healthcare leaders that generate consistent revenue and profits. They also have attractive long-term prospects and have consistently raised their dividend payouts.
These Analysts Increase Their Forecasts On Medtronic After Strong Q2 Earnings
Medtronic Plc (NYSE: MDT) on Tuesday reported strong second-quarter 2026 results.
S&P 500 Gains and Losses Today: Home Depot Slumps as Earnings Disappoint; Medtronic Stock Jumps
Shares of a major home improvement retailer lost ground after it missed quarterly profit forecasts, indicating homeowners are putting off remodeling projects amid economic uncertainty. Meanwhile, stro...
Medtronic plc (MDT) Q2 2026 Earnings Call Transcript
Medtronic plc ( MDT) Q2 2026 Earnings Call November 18, 2025 8:00 AM EST Company Participants Ryan Weispfenning - VP & Head of Investor Relations Geoffrey Martha - Chairman of the Board & CEO Thierry...
Medtronic Lifts Outlook as Quarterly Profit, Sales Rise
Medtronic raised its fiscal-year outlook after logging higher profit and sales in its latest quarter, boosted by robust demand across end markets and healthy procedure volumes.
Medtronic Stock Rises After Earnings. What Caught Investors' Attention.
Medtronic exceeds fiscal second-quarter earnings and revenue expectations.
Medtronic beats second-quarter estimates on strength in heart devices segment
Medical device maker Medtronic topped Wall Street estimates for second-quarter profit and revenue on Tuesday, driven by strong demand for its heart disease and diabetes devices.
Medtronic reports strong second quarter fiscal 2026 financial results, enterprise growth drivers accelerate momentum
Cardiac Ablation Solutions growth of 71% on strength of pulsed field ablation (PFA) portfolio; Raising FY26 revenue and EPS guidance GALWAY, Ireland , Nov. 18, 2025 /PRNewswire/ -- Medtronic plc (NYSE...
Top Wall Street Forecasters Revamp Medtronic Expectations Ahead Of Q2 Earnings
Medtronic plc (NYSE: MDT) will release earnings results for the second quarter, before the opening bell on Tuesday, Nov. 18.
2 Giant Healthcare Stocks to Buy Hand Over Fist in November
Medical device maker Medtronic boasts an attractive yield and a long history of dividend growth. Pfizer is demonstrating its ability to make the necessary moves to rebuild its drug pipeline.
Minze Health Announces Collaboration with Medtronic to Support Patients with Overactive Bladder in EMEA
ANTWERP, Belgium--(BUSINESS WIRE)--Minze Health partners with Medtronic to integrate its automated bladder diary, Minze Diary Pod, into Sacral Neuromodulation care for OAB patients.
Medtronic: Possible Earnings Beat Incoming But Still Overvalued
Medtronic plc offers stable dividends and consistent cash flow, but growth remains lackluster with revenues plateauing and limited expansion prospects. MDT's product pipeline, especially in cardiovasc...
Intuitive Surgical Is the Robotic-Assisted Surgery Leader, but Medtronic Is Making Moves. Here's What Investors Need to Know.
Intuitive Surgical's da Vinci surgical robot is an industry leader in one specific area. Medtronic offers both a surgical robot and a more diverse business beyond it.